Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment
Radiation Oncology Journal. 2016;34(1):1-9 
Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Current Treatment Standards and Future Perspectives
Breast Care. 2020;15(6):570-578
Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer
Breast Cancer. 2013;20(2):103-110
Expanding Treatment Arsenal for Oestrogen Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
Hong Kong Journal of Radiology. 2019;22(2):86-97
Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancer
Breast Cancer Research and Treatment. 2021;
Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer
OncoTargets and Therapy. 2016;Volume 9:6119-6125
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Cancer Management and Research. 2016;Volume 8:85-94
Survival Outcomes In Human Epidermal Growth Factor Receptor 2 (HER 2) Positive Breast Cancer Patients At Kenyatta National Hospital
. 2021;
Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Cancer Management and Research. 2016;Volume 8:127-128
Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer
Breast Cancer Research and Treatment. 2012;137(2):523-531